Winship study published in The Lancet shows increased failure-free survival in prostate cancer
Dec 19, 2023
Treatment guided by molecular imaging technology invented and developed by researchers at Winship Cancer Institute of Emory University shows improved disease-free survival rates for men who have undergone surgical removal of their prostate, according to findings published in the medical journal The Lancet. The randomized trial enrolled 165 patients whose cancer recurred after having their prostates removed. One group received radiation therapy using conventional imaging while the other received treatment using imaging with the fluciclovine PET radiotracer. The study found that 75.5 percent of those whose treatment integrated fluciclovine PET were disease-free after three years, compared to 63 percent for those where only conventional imaging techniques were used to plan treatment. The increased failure-free survival rate persisted after four years of follow up.
Radiation Oncologists Met With Congressional Leaders to Reverse CMS Cuts and Provide Equal Access to Care
Radiation oncologists met with Congress to urge leaders to consider how the Medicare and Medicaid Services (CMS) proposal to make significant cuts to radiation oncology facilities could be detrimental to the survival of patients with Read more…
FDA Approves Neoadjuvant Pembrolizumab Combination for Early TNBC Indication
The FDA granted approval to the supplemental biologics license application (sBLA) for pembrolizumab (Keytruda) as neoadjuvant therapy for patients with high-risk early-stage triple-negative breast cancer (TNBC) when given in combination with chemotherapy followed by single-agent Read more…
Recommended TVUS Screening Thresholds May Miss Endometrial Cancer in Black Women
Adherence to current clinical guidelines for the evaluation of postmenopausal bleeding may result in systematic underdiagnosis of endometrial cancer (EC) in Black women, according to a study published online July 15 in JAMA Oncology. Kemi M. Read more…